Website
Recent investment activity
KANDO id: 106781
Corporate information
Registration country
Funding rounds
Acquisition USD 20,000,000,000
USD 20,000,000,000 ( ) at USD 20,000,000,000 pre-money valuation
Investor | Profile | Country | Notes | |
---|---|---|---|---|
Sanofi Aventis | USD 20,000,000,000 (USD 20,000,000,000) Initial investment. |
Investor | Profile | Country | |
---|---|---|---|
Kleiner Perkins Caufield & Byers LLC (KPCB) | Venture capital firm. |
Actual initial investment stage
Series B (1)
Investment activity status
Active investor
Selected investments
Displaying 1 - 5 of 5Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Bluebird Bio Inc | Developer of an innovative gene therapies for severe genetic disorders | Series B | ||||
GelTex Pharmaceuticals | Acquisition 1,000,000,000 (USD 1,000,000,000) | |||||
ILEX Oncology Inc | N/A | |||||
Sirtris Pharmaceuticals Inc | Series C | |||||
Fate Therapeutics Inc | Series B Initial investment |